File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3109/17482941.2011.567283
- Scopus: eid_2-s2.0-80052453860
- PMID: 21517667
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Low molecular weight heparin versus unfractionated heparin for thromboprophylaxis in patients with acute atrial fibrillation: A randomized control trial
Title | Low molecular weight heparin versus unfractionated heparin for thromboprophylaxis in patients with acute atrial fibrillation: A randomized control trial |
---|---|
Authors | |
Keywords | Heparin Stroke |
Issue Date | 2011 |
Publisher | Informa Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/14628848.asp |
Citation | Acute Cardiac Care, 2011, v. 13 n. 3, p. 196-198 How to Cite? |
Abstract | While long-term anticoagulation prevents ischemic stroke in high-risk patients with atrial fibrillation (AF), the optimal initial anti-thrombotic regime in acute AF is less well defined. We randomized 96 patients with new onset acute AF in an emergency admission ward to receive (1) once-daily preparation of low molecular weight heparin (LMWH), tinzaparin or (2) conventional intravenous unfractionated heparin (target APTT 5070 s). 5 patients in unfractionated heparin group compared with no patients in LMWH group (0%, P = 0.04) developed ischemic stroke/transient ischemic attack during the first 48 h. An initial subcutaneous LMWH was safe and effective in ischemic stroke prevention in patients with acute AF. © 2011 Informa UK, Ltd. |
Persistent Identifier | http://hdl.handle.net/10722/135232 |
ISSN | 2019 SCImago Journal Rankings: 0.113 |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Siu, CW | en_HK |
dc.contributor.author | Jim, MH | en_HK |
dc.contributor.author | Lau, CP | en_HK |
dc.contributor.author | Tse, HF | en_HK |
dc.date.accessioned | 2011-07-27T01:30:22Z | - |
dc.date.available | 2011-07-27T01:30:22Z | - |
dc.date.issued | 2011 | en_HK |
dc.identifier.citation | Acute Cardiac Care, 2011, v. 13 n. 3, p. 196-198 | en_HK |
dc.identifier.issn | 1748-2941 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/135232 | - |
dc.description.abstract | While long-term anticoagulation prevents ischemic stroke in high-risk patients with atrial fibrillation (AF), the optimal initial anti-thrombotic regime in acute AF is less well defined. We randomized 96 patients with new onset acute AF in an emergency admission ward to receive (1) once-daily preparation of low molecular weight heparin (LMWH), tinzaparin or (2) conventional intravenous unfractionated heparin (target APTT 5070 s). 5 patients in unfractionated heparin group compared with no patients in LMWH group (0%, P = 0.04) developed ischemic stroke/transient ischemic attack during the first 48 h. An initial subcutaneous LMWH was safe and effective in ischemic stroke prevention in patients with acute AF. © 2011 Informa UK, Ltd. | en_HK |
dc.language | eng | en_US |
dc.publisher | Informa Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/14628848.asp | en_HK |
dc.relation.ispartof | Acute Cardiac Care | en_HK |
dc.rights | Acute Cardiac Care. Copyright © Informa Healthcare. | - |
dc.subject | Heparin | en_HK |
dc.subject | Stroke | en_HK |
dc.subject.mesh | Atrial Fibrillation - drug therapy - pathology | - |
dc.subject.mesh | Fibrinolytic Agents - administration and dosage - therapeutic use | - |
dc.subject.mesh | Heparin - administration and dosage - therapeutic use | - |
dc.subject.mesh | Heparin, Low-Molecular-Weight - administration and dosage - therapeutic use | - |
dc.subject.mesh | Infusions, Intravenous | - |
dc.title | Low molecular weight heparin versus unfractionated heparin for thromboprophylaxis in patients with acute atrial fibrillation: A randomized control trial | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Siu, CW:cwdsiu@hkucc.hku.hk | en_HK |
dc.identifier.email | Tse, HF:hftse@hkucc.hku.hk | en_HK |
dc.identifier.authority | Siu, CW=rp00534 | en_HK |
dc.identifier.authority | Tse, HF=rp00428 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.3109/17482941.2011.567283 | en_HK |
dc.identifier.pmid | 21517667 | - |
dc.identifier.scopus | eid_2-s2.0-80052453860 | en_HK |
dc.identifier.hkuros | 187310 | en_US |
dc.identifier.hkuros | 201287 | - |
dc.identifier.hkuros | 208713 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-80052453860&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 13 | en_HK |
dc.identifier.issue | 3 | en_HK |
dc.identifier.spage | 196 | en_HK |
dc.identifier.epage | 198 | en_HK |
dc.publisher.place | United Kingdom | en_HK |
dc.identifier.scopusauthorid | Siu, CW=7006550690 | en_HK |
dc.identifier.scopusauthorid | Jim, MH=6603860344 | en_HK |
dc.identifier.scopusauthorid | Lau, CP=7401968501 | en_HK |
dc.identifier.scopusauthorid | Tse, HF=7006070805 | en_HK |
dc.identifier.issnl | 1748-2941 | - |